DCRI Late-Breakers at AHA.22

DCRI Late-Breakers at AHA.22

Turning Knowledge into Practice

MentzHeadshot

Nov. 5, 2022  |  9:30-9:42 a.m.  |  Main Event I

Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure:
Primary Results of the TRANSFORM-HF Trial

Presented by DCRI Faculty Robert Mentz, MD

Nov. 6, 2022  |  8:13-8:23 a.m.  |  Main Event I

Steroids to Reduce Systemic Inflammation
After Infant Heart Surgery:
The STRESS Trial

Presented by DCRI Faculty Kevin Hill, MD

Headshot of Kevin Hill, MD
Headshot of Pamela Douglas, MD

Nov. 6, 2022  |  5:26-5:36 p.m.  |  Main Event II

Comparison of a Precision Care Strategy With Usual Testing to Guide Management of Stable Patients With Suspected Coronary Artery Disease:
The Precise Randomized Trial

Presented by DCRI Faculty Pamela Douglas, MD

Nov. 7, 2022  |  8:37-8:40 a.m.  |  Main Event I

Preventing Limb Loss Through Vascular Interventions and Venous Therapies:
PREVENT HD

Featuring DCRI Faculty discussant Renato Lopes, MD

AHA-2019_Renato-Lopes-1024x680
Headshot of Jonathan Piccini, MD

Nov. 7, 2022  |  11:26-11:36 a.m.  |  Main Event I

Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation in Cardiac Surgery Patients:
Results From the Phase 2 Nova Study

Presented by DCRI Faculty Jonathan Piccini, MD

dcri_AHA_qr_code

 

Scan the QR code to view all DCRI events and news at AHA.22

AHA Promo Card 2022